Notice Number: NOT-EB-18-015

Key Dates
Release Date: April 30, 2018

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering (NIBIB) will participate, effective immediately, in RFA-HL-19-016
"Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 Clinical Trial Not Allowed)."

The following changes and updates are made to RFA-HL-19-016 (shown in italics) to reflect NIBIB participation in this FOA.

Part 1. Overview Information

National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.837, 93.838, 93.839, 93.233, 93.840, 93.286

Section VII. Agency Contacts

Scientific/Research Contact(s)

Erin Iturriaga, RN, BS, MSN
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0403
Email: [email protected]

Tiffani Bailey Lash, Ph.D.
National Institute of Biomedical Imaging and Bioengineering NIBIB
Telephone: 301-451-4778
Email: [email protected]

Financial/Grants Management Contact(s)

Ann Marie Brasile Mejac
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8016
Email: [email protected]

Angelos Bacas
NIBIB Grants Management Specialist
Telephone: 301-451-4785
Email: [email protected]

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Tiffani Bailey Lash, Ph.D.
National Institute of Biomedical Imaging and Bioengineering NIBIB
Telephone: 301-451-4778
Email: [email protected]